All In MedTech

PMA device

LINX Reflux Management System

Torax Medical · Implant, Anti-Gastroesophageal Reflux (LEI, Class III) · First FDA decision Mar 22, 2012, newest Oct 8, 2025Acid reflux (GERD)

Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed

FDA decisions

12

PMA pathway

Device trials

11

Naming "LINX"

MAUDE reports

2,110

Brand "LINX", since 2015

PubMed studies

205

Mentioning "LINX"

AI summary across all sources

Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.

Product review deck

A slide deck reviewing LINX Reflux Management System

About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.

  • Executive summary and key facts
  • Technology
  • Clinical evidence and trials
  • Regulatory history and safety
  • Reimbursement, market and competition
  • Risks, outlook and sources

AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.

FDA decisions

The newest 6 of 12 decisions filed under this name.

3 more FDA decisions with a free account

Older decisions: P100049-S011, P100049-S004, P100049-S003, P100049-S002, P100049-S001, P100049

Medicare coverage

National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.

How devices get paid for

No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.

Clinical trials

Device studies on ClinicalTrials.gov that name "LINX", any status and sponsor, newest update first.

Open in Trial Radar
  • RETHINK REFLUX RegistryActive, not recruiting

    Ethicon Endo-SurgeryPublic (JNJ)

    NCT04253392 · 500 participants · Start Jul 8, 2020 · Primary completion Jul 31, 2032

    Device: LINX Reflux Management System · For: Gastroesophageal Reflux

    Sites: Mobile, Alabama; Tucson, Arizona; Los Angeles, California · 28 sites in all

  • MicroTech Medical(Hangzhou)Co.,Ltd.Not on our public-company list

    NCT07802327 · 100 participants (planned) · Start Sep 2026 · Primary completion Feb 2028

    Device: GX-01S Continuous Glucose Monitoring System · For: Diabetes Mellitus; Diabetes Mellitus ( Type 1 and Type 2)

  • Ramathibodi HospitalAcademic, hospital or other

    NCT07533604 · 45 participants (planned) · Start Jan 20, 2026 · Primary completion Sep 1, 2026

    Device: SnapD; Linx CGM · For: Type2 Diabetes Mellitus

    Sites: Bangkok, Thailand

8 more trials with a free account

Adverse event reports (MAUDE)

Reports received since 2015 naming the brand "LINX", and for the whole product code for context.

This brand

2,110 reports: 95 malfunction, 2,013 injury, 1 death

Whole product code LEI

2,179 reports: 98 malfunction, 2,079 injury, 1 death

Newest reports for this brand

2 more reports with a free account

All reports in MAUDE Monitor

Recalls

From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.

2 more recall records with a free account

Published research

The most relevant PubMed records for "LINX"[tiab]. The summary above synthesizes these.

PubMedGoogle ScholarLiterature search

Other devices of this type

Also filed under product code LEI.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.